Second-trimester maternal pregnancy-associated plasma protein a and inhibin a levels in fetal trisomies

Fetal Diagn Ther. 2002 May-Jun;17(3):137-41. doi: 10.1159/000048026.

Abstract

Objective: The aim of this study was to determine whether fetal trisomy is associated with altered levels of second-trimester maternal pregnancy-associated plasma protein A (PAPP-A) and inhibin A.

Methods: Maternal serum PAPP-A and inhibin A concentrations were measured at 15-17 weeks of gestation in 14 singleton pregnancies with fetal trisomy and in 56 matched pregnant controls.

Results: PAPP-A levels in the trisomy group were significantly lower than in controls. The inhibin A level with fetal trisomy 21 was slightly higher than the control group, but levels were not different between trisomies 18 and 13 and controls.

Conclusion: Fetal trisomies 21, 18, and 13 are associated with a reduction in second-trimester maternal PAPP-A levels; trisomies 18 and 13 are not associated with increased inhibin A levels, unlike trisomy 21.

MeSH terms

  • Adult
  • Chromosomes, Human, Pair 13
  • Chromosomes, Human, Pair 18
  • Down Syndrome / genetics
  • Female
  • Gestational Age*
  • Humans
  • Inhibins / blood*
  • Maternal Age
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy, High-Risk
  • Pregnancy-Associated Plasma Protein-A / analysis*
  • Trisomy*

Substances

  • inhibin A
  • Inhibins
  • Pregnancy-Associated Plasma Protein-A